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(iPSCs) have served as a versatile and powerful tool not only for basic research but also with the long-term goal of using them in human
cell transplantation after differentiation. Nonetheless, downstream applications are frequently blurred by the difficulties that researchers
have to face when working with iPSCs, such as trouble with clonal selection, in vitro culture and cryopreservation, adaptation to feeder-
free conditions, or expansion of the cells. Therefore, in this article we aim to provide other researchers with practical and detailed in-
formation to successfully culture and adapt iPSCs. Specifically, we (1) describe the most common problems when in-vitro culturing
iPSCs onto feeder cells as well as its possible troubleshooting, and (2) compare different matrices and culture media for adapting the
iPSCs to feeder-free conditions. We believe that the troubleshooting and recommendations provided in this article can be of use to other
researchers working with iPSCs and who may be experiencing similar issues, hopefully enhancing the appeal of this promising cell
source to be used for biomedical investigations, such as tissue engineering or regenerative medicine applications.BACKGROUND ramming methods and iPSC culture strategies initially involved theReceived 26 May 2021; accepted 29 October 2021;
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indefinitely in culture without reduction of the quality, besides poten-
tial of differentiation into any desired cell type.1 Therefore, when first
discovered in 2006,2 these cells were thought to be the “panacea” for
biomedical applications. In the case of tissue engineering, iPSCs hold
great potential for personalized tissues, which can be used for regen-
erative medicine and/or in vitro studies to tailor other medical inter-
ventions.3 However, all these advantages and potential applications
are blurred by the difficulties that researchers have to face when work-
ing with iPSCs, such as trouble with clonal selection, in vitro culture,
adaptation, and/or expansion of the cells.4 iPSCs’ recovery after
freezing is still an issue5,6 and, in addition, it has been reported that
iPSC colonies may disappear and break up into single cells during
initial colony morphology-based selection.7
The use of iPSCs in all downstream applications requires the
establishment of protocols that will allow large-scale, cost-effective
cultivation of cells, without compromising on their quality.8 Reprog-Molecular Therapy: Methods & Clinic
This is an open access article under tuse of mouse or human feeder layers, thus coinciding with the proto-
col established by Thomson for in vitro culturing embryonic stem
cells (ESCs).9 These feeder cells secrete essential growth factors, extra-
cellular matrix components, and cytokines into the culture media,
which support pluripotent cell growth and proliferation.8,10,11
Although a robust method, feeder-based systems are labor intensive,
hard to scale,11 and can also be a source of animal pathogens and my-
coplasma contamination.8,11,12 Moreover, this system does not allowal Development Vol. 23 December 2021 ª 2021 The Author(s). 569
he CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ated iPSC lines, since feeder cells can interfere with molecular and/
or flow cytometry experiments.13 This is why in certain occasions
iPSCs have to be “moved” to feeder-free culture systems. But when
pluripotent cells are switched from one cell culture condition to
another, they need to adapt to the new system to regain homeosta-
sis14; this adaptation process is usually harmful for the cells, especially
in the case of newly derived cell lines, often experiencing more differ-
entiation and apoptosis than normal.14–16 Despite feeder-free reprog-
ramming being proven feasible,6,17–19 feeder-based reprogramming
methods are still the most common surface on which to develop
the reprogramming process.6,20
In our group we have recently published the successful generation of
three iPSC lines derived from human skin fibroblasts.21,22 It is worth
mentioning that the problems that we had to face during the process
of generation and characterization of the cells were numerous, espe-
cially regarding the adaptation to feeder-free conditions. There are
currently a lot of published combinations of matrices and culture me-
dia to replace feeder layers (reviewed in Dakhore et al.,8 Sams and
Powers,11 Skottman and Hovatta,13 Liu et al.,20 Anderson et al.,23 Na-
kamura et al.,24 Kishimoto et al.25). But when consulting the bibliog-
raphy for troubleshooting, we could just find depthless explained
methodology. It is widely known that generation and in vitro culture
of iPSCs is a slow and tricky process,8,26 but the literature rarely ex-
plains the difficulties and problems found during the process of estab-
lishing new iPSC lines and daily working with them. Therefore, in this
methodological article we aim to fill in this gap of knowledge by
deeply describing the protocols we established for the complex pro-
cess of generating iPSC lines. Special attention is paid to (1) which
are the most common problems when in-vitro-culturing iPSCs onto
feeder cells as well as its possible troubleshooting, and (2) comparing
different matrices and culture media for adapting the iPSCs to feeder-
free conditions.
We strongly believe that reporting this kind of problems and suggest-
ing possible ways to have them solved will contribute to help other re-
searchers that might have similar issues when working with iPSCs.
REQUIRED MATERIALS
Reagent list
 Basic fibroblast growth factor (bFGF) (13256029, Gibco Thermo
Fisher Scientific)
 Bovine serum albumin (BSA) 9048-46-8, Sigma)
 Dimethyl sulfoxide (DMSO) (67-68-5, Sigma-Aldrich Química
SA)
 Dulbecco’s modified Eagle’s medium (DMEM) (12-604F, Lonza)
 DMEM knockout without L-glutamine (KO-DMEM); (10829018,
Gibco Thermo Fisher Scientific)
 DPBS with calcium and magnesium (14040133, Gibco Thermo
Fisher Scientific)
 Fluorescence-activated cell sorting buffer (Becton Dickinson)
 Fetal bovine serum (FBS) (10082147, Gibco Thermo Fisher Scien-
tific)570 Molecular Therapy: Methods & Clinical Development Vol. 23 Decem Gentle cell dissociation reagent (07174, STEMCELL Technologies)
 Geltrex hESC-qualified, ready-to-use, reduced growth factor base-
ment membrane matrix (A1569601, Gibco)
 GlutaMAX 100X (35050061, Gibco Thermo Fisher Scientific)
 Human foreskin fibroblasts, HFF-1 cell line (CRL2429, ATCC)
 Iscove’s modified Dulbecco medium (IMDM) (12440053; Gibco
Thermo Fisher Scientific)
 Knockout serum replacement (10828028, Gibco Thermo Fisher
Scientific)
 2-Mercaptoethanol (50 mM; 31350010, Gibco Thermo Fisher Sci-
entific)
 Matrigel basement membrane matrix (354234, Corning)
 Non-essential amino acids 100X (11140050, Gibco Thermo Fisher
Scientific)
 Phosphate-buffered saline tablets (BR0014G, Oxoid)
 Phosphate-buffered saline with Ca2+ and Mg (14287, Thermo
Fisher Scientific)
 Penicillin/streptomycin (P/S) (15140122, Gibco Thermo Fisher
Scientific)
 Propidium iodide (PI) (P4170, Sigma-Aldrich)
 rh-Laminin-521 521 (A29249; Thermo Fisher Scientific)
 RNAse (500 mg/mL; Roche)
 RevitaCell 100X (A2644501; Gibco)
 ROCK inhibitor Y-27632 (04-0012, Stemgent)
 Saline serum (154 mmol/L Na and 154 mmol/L Cl–, Fresenius
Kabi)
 StemFlex basal medium (A3349301, Gibco Thermo Fisher Scienti-
fic)
 StemFlex Supplement 10X (A3349201, Gibco Thermo Fisher Sci-
entific)
 Trypan blue staining (T8154-20 ML, Sigma)
 TrypLE Select Enzyme (1X), no phenol red (12563011, Gibco
Thermo Fisher Scientific)
 Versene solution (15040066, Gibco)
 0.05% trypsin-EDTA (25300054, Gibco)
 0.25% trypsin-EDTA (25200056, Gibco)Equipment list
 0.22-mm filter (GSWP14250, Millipore)
 15- and 50-mL conical tubes
 175 mm “stripper” tips (Gynétics)
 Cryovials, 1.5 mL
 FACScalibur flow cytometer (Becton Dickinson) and CellQuest
software (Becton Dickinson)
 CoolCell freezing container
 Neubauer chamber
 Polypropylene conical tubes (Corning Science)
 Real-time DS-FI2 photomicrograph camera
 Sight DS-L3 digital control monitor
 SMZ-745T stereomicroscope
 Stripper micropipette (Origio Midatlantic Devices)
 100- and 150-mm tissue culture dishes
 Six-well tissue culture platesber 2021
Figure 1. Picking iPSC colonies
(A) Setup of the SMZ-745T stereomicroscope coupled to a real-time DS-FI2
photomicrograph camera and a Sight DS-L3 digital control monitor inside the
laminar flow hood. (B) Representative image of one iPSC colony with the desired
morphology cultured onto feeder cells.
Scale bar, 50 mm.
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 5% DMEM medium: DMEM supplemented with 5% FBS and 1%
P/S. Store at 4C.
 bFGF: 100 mg/mL stock solution of bFGF in 2% filter sterilized
BSA. Divide into usage size aliquots (50 mL). Store at 20C.
 CRYOSTEM hPSC freezing medium (Cellseco Biological Indus-
tries).
 Freezing medium: 90% FBS and 10% DMSO. The use of freshly
made freezingmedium is recommended. Alternatively, freezingme-
dium can be prepared and stored at 4C in darkness up to 1 month.
 hES medium: KO-DMEM containing 20% knockout serum
replacement, 1% non-essential amino acids, 1% GlutaMAX
100X, 1% P/S, 0.1 mM b-mercaptoethanol (0.5 mL of a 50 mM
stock solution), and 100 mg/mL bFGF (all from Gibco). Store at
4C and use within 1 month. Do not pre-warm the whole bottle.
 HFF medium: IMDM supplemented with 10% FBS and 1% P/S.
Store at 4C.
 Matrigel solution: thaw Matrigel basement membrane matrix
slowly at 4C overnight on ice. While working on ice inside a
laminar flow hood, Matrigel solution is prepared at 1:40 dilution
in P/S and KO-DMEM. Cool the pipette by aspirating cold KO-
DMEM up and down 10–20 times. Using a cold pipette, aseptically
transfer Matrigel to KO-DMEM. Invert the solution several times
to obtain homogeneous Matrigel solution. Do not shake again
and store at 4C.
 rh-Laminin-521: thaw rh-laminin-521 between 2C and 8C, mix
gently by inversion 3–5 times, divide into usage size aliquots
(300 mL recommended) in polypropylene tubes and store at
20C until expiration date. Avoid extended exposure of protein
to ambient temperatures.
 ROCK inhibitor Y-27632: reconstitute in DMSO to prepare a stock
solution of 10 mM and divide into aliquots of 10 mL. Store aliquots
at 20C up to 6 months.
 StemFlex complete medium: thaw the frozen StemFlex Supplement
10X at room temperature (RT) for 2 h or overnight at 4C. Mix
the thawed supplement by gently inverting 3–5 times. Aseptically
transfer 50 mL of StemFlex Supplement 10X to
the bottle of StemFlex basal medium. Gently invert the bottle
several times to obtain an homogeneous complete medium.
Aliquot the medium and store at 20C for up to 6 months. To
avoid multiple freeze-thaw cycles, we recommend preparing 25-
and 50-mL aliquots and use as needed. Before use, warm complete
medium required for that day at RT until it is no longer cool to the
touch.
 Vitronectin (VTN-N) recombinant human protein, truncated
(0.5 mg/mL). Thaw the vial of vitronectin at RT and prepare 60-
mL aliquots of vitronectin in polypropylene tubes. Freeze the ali-
quots at 80C or use immediately.
Equipment setup
 For themanual picking of iPSC colonies, equip a laminar flow hood
with a stereomicroscope coupled to a real-time camera that allows
for visualizing the iPSC colonies while working inside the laminar
flow hood (Figure 1A).Molecular TheEXPERIMENTAL PROCEDURE
Note: all of these protocols must be performed in a sterile manner. All
reagents, except for BSA, are suitable for cell culture and there is no
need of filter sterilization.
Note: optimization and testing of the protocols included in this manu-
script has been performed using three iPSC lines previously generated
in our laboratory: N1-FiPS4F#7, MOA1-FiPS4F#7, and MOA2-
FiPS4F#17.19,22
Preparation of a stock of feeder cells
Note: generating a stock of feeder cells is necessary for performing cell
reprogramming and sub-culturing of iPSC colonies. The protocol we
recommend here is based on mitotically inactivating the foreskin fibro-
blast cell line HFF-1 with g-irradiation, but other methods for
arresting cell cycle such as mitomycin C can be used.27
Expansion of the cells and irradiation
1. Before performing the irradiation process, culture the HFF-1 cell
line in IMDM supplemented with 10% FBS and 1% P/S (HFF me-
dium), at 37C in a humidified atmosphere with 5% CO2.rapy: Methods & Clinical Development Vol. 23 December 2021 571
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for cell expansion until sufficient numbers of cells (approxi-
mately 6–10, 150-cm2 culture dishes at 100% confluence) are ob-
tained.
Note: do not over expand the HFF-1 before irradiation. Too many
cells will result in too many frozen cryovials. We do not recommend
using feeder cells that have been stored for longer than 3 months in
liquid nitrogen since they tend to deteriorate. This makes the iPSC
colonies more likely to break up into single cells and disappear in
culture.
3. On the day of irradiation, remove the HFFmedium from the plates
and wash the cells twice with PBS.
4. Incubate the HFF-1 cell line with 0.25% trypsin-EDTA for 2–
3 min at 37C.
5. To verify that cells are not still adhered to the culture dish, visualize
the plates through an inverted microscope.
6. When HFF-1 cells are detached from the culture dishes, inactivate
the trypsin-EDTA with a double volume of 5% DMEM.
7. Collect cell suspension in a 50-mL conical tube and centrifuge for
7 min at 400  g to obtain a cell pellet.
8. Resuspend the cell pellet in 50 mL of warm HFF medium.
9. Immediately irradiate the HFF-1-containing tube at 75 Gy. In this
protocol we used a Varian Unique linear accelerator (Centro On-
cológico de Galicia, Spain).
Note: if performing this protocol for the first time, and due to possible
differences in the accelerators used, we recommend verifying that
75 Gy irradiation inhibits HFF-1 mitosis by flow cytometry as
described below.
Cell-cycle evaluation by flow cytometry
Here, the cell cycle is evaluated by flow cytometry and using PI.
1. Transfer 2  105 cells to polypropylene conical tubes and centri-
fuge at 400  g for 5 min.
2. Wash the pelleted cells twice with saline serum.
3. Discard the supernatant and resuspend pelleted cells in a solution
composed of 350 mL PI (stock concentration 1.0 mg/mL) and
1.5 mL RNAse (stock concentration 500 mg/mL) per tube.
4. Incubate the tubes in the dark for 15 min and then centrifuge for
5 min at 400  g.
5. Resuspend the pellets in fluorescence-activated cell sorting buffer
to a final volume of 200 mL.
6. Analyze the cells in a FACScalibur flow cytometer using the Cell-
Quest software.
Note: non-irradiated HFF-1 cells must be also analyzed as negative
control.
Cryopreservation of feeder cells
1. Count the irradiated HFF-1 cells using trypan blue staining and a
Neubauer chamber.
2. Centrifuge the cell suspension for 7 min at 400  g.572 Molecular Therapy: Methods & Clinical Development Vol. 23 Decem3. While centrifuging, prepare the necessary amount of freezing me-
dium according to cell count and considering 1 mL for every 2 
106 cells, and place it on ice.
4. Resuspend pelleted cells in cold (2C–8C) freezing medium.
Note: we recommend adjusting the volume of freezing medium ac-
cording to cell count to cryopreserve 2  106 cell/mL.
Note: at this point it is recommended to work as fast as possible (±
5 min) until the cryovials are introduced in the freezer since exposure
of the cells to DMSO at RT is toxic for the cells.28
5. Introduce cryovials containing 1 mL of the cell suspension in a
freezing container (e.g., CoolCell) and store at 80C for 24 h.
6. After 24 h, transfer the cryovials to liquid nitrogen until used.
Thawing of feeder cells
1. Thaw feeder cells by quickly introducing the cryovials in a 37C
water bath.
Note: the water bath should be cleaned periodically with addition of
water bath disinfectants (e.g., Sigmaclean).
2. Gently shake the cryovial until only a small piece of ice remains.
Note: do not completely submerge the cryovial in the water bath or
contamination of the feeders may occur.
3. At this point, spray the cryovial with 70% ethanol and place inside
the laminar flow hood.
4. Collect the cell suspension with a micropipette and transfer in a
dropwise manner to a 15-mL conical tube containing pre-warmed
5% DMEM.
5. To remove the freezing medium, centrifuge tubes with the cell sus-
pension at 400  g for 5 min.
6. Discard the supernatant and resuspend pelleted cells in 2 mL/well
of hESC medium to seed the feeders in six-well culture dishes (see
“Culture of iPSCs onto feeder cells”).
Note: we recommend that one cryovial with 2  106 cells be used to
prepare four to five confluent wells of a six-well culture dish (cell den-
sity of ±4  104 cells/cm2).Culture of iPSCs onto feeder cells
Seeding of feeder cells on six-well plates
1. For preparation of the six-well plates, add 1.5 mL of cold Matrigel
solution (see “reagent setup,” for tips on how to prepare Matrigel
solution) to each well, ensuring that the solution completely covers
the bottom of the dish, and incubate for at least 1 h at RT inside a
laminar flow hood.
2. Approximately 10 min before the 1-h incubation finishes, thaw the
feeder cells (see “Preparation of a stock of feeder cells,” thawing of
feeder cells).
3. Aspirate Matrigel solution and seed the feeder cells as described
above.ber 2021
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to damage the coating of the wells.
4. Move the six-well plates in a cross-shapedmanner to ensure evenly
distribution of the feeder cells.
5. Incubate the plates with feeder cells in 2 mL/well of hESC medium
for 48 h at 37C, normoxia, and 5% CO2 before seeding the iPSCs
colony fragments to allow the feeder cells to settle in culture and
avoid unwanted spreading over the iPSCs.
Picking iPSC colonies
1. Identify the iPSC colonies with the right morphology (i.e.,
compact colonies with well-defined edges and comprised of cells
with high nucleus/cytoplasm ratio)29,30 and that grow robustly
(Figure 1B).
2. Prepare and turn on the stereomicroscope.
3. Prepare the stripper micropipette and its 175-mm tips.
4. Replace hESC medium with 2 mL of fresh warm hESC medium in
the six-well feeder plates that have been prepared 48 h in advance.
The number of wells prepared should be adjusted depending on
the number of ready to pick colonies considering a general 6:1 ra-
tio, meaning six healthy iPSC colonies per new well of a six-well
plate.
Note: when refreshing the hESCmedium of the wells to which colony
fragments will be transferred, leave ±0.5 mL of old medium in the
well. This will help to keep the growth factors and cytokines secreted
by the feeder cells.
Note: do not prepare the plates more than 48 h in advance.
5. Bring both six-well plates (i.e., the one containing the iPSC col-
onies to be picked and the one containing the new feeder cells)
to the laminar flow hood.
6. Carefully break up the selected iPSC colonies into small fragments
while lifting and aspirating them by using a stripper micropipette
and its 175-mm tips, as shown in Figure 1A and Video S1.
Note: to ensure healthy iPSCs cultures, it is of uttermost importance
not to pick the differentiated areas of the colonies.
7. Gently transfer fragments of colonies into a new well with feeder
cells in a 6:1 ratio, meaning six healthy iPSC colonies per new
well of a six-well plate.
Note: this ratio allows iPSC colonies to grow within 5–9 days in cul-
ture and with enough space to avoid touching colonies and, as such,
unwanted differentiation. Please, consider that empirical determina-
tion of the optimal ratio may be required.
8. Once a six-well plate is completed, transfer it to the incubator and
delicately move it in a cross-shaped manner to homogeneously
distribute the fragments.
9. Leave the plates undisturbed inside the incubator for 48 h.
10. From 48 h onward, replace hESC medium daily.Molecular TheNote: we recommend not aspirating all the medium, but to
leave ±0.5 mL of medium before adding 2 mL of fresh hESC medium.
11. Clonal iPSCs lines are established by manually picking human
ESC-like colonies every 5–9 days, depending on the clone (Fig-
ure 1B).
Note: these time values differ in comparison with the growth period
before the first split, after reprogramming of the somatic cells. In this
case, iPSC colonies should be first picked after 26–32 days in culture,
depending on the clone.Creating the iPSC batch
Freezing iPSCs
Note: in this study, we tested two types of freezing media, one
commercially available (CRYOSTEM, Stem Cell; Option A) and
one prepared in our laboratory (freezing medium; see reagent setup
section; Option B).
Note: for both option A and option B, the remaining colonies from
previously picked wells are kept, and leftover colonies are picked
again for freezing. Also, when the iPSC lines are established (approx-
imately at passages 10–15) the split ratio can be doubled and wells
with colonies that had not been previously picked can be used entirely
for freezing.
1. Proceed as described in the section above (“Picking iPSC col-
onies”) until step number 3.
2. Bring the selected six-well plate to the laminar flow hood.
3. Carefully break up all the colonies (typically ±10) in each well as
shown in Video S2.
4. Aspirate independently the hESC medium containing the colony
fragments of each well with a 5-mL pipette and transfer the sus-
pension to 15-mL conical tubes.
5. Centrifuge the suspensions at 280  g for 2–4 min at RT.
6. While centrifuging, prepare and label the required number of
cryovials (i.e., one cryovial per well to be frozen).
7. Carefully aspirate the supernatant paying attention to keep the
cell pellet intact.
8. Gently tap the tubes with pelleted iPSCs, hanging the tube with
one hand and tapping the bottom of the tube with the other, mov-
ing the fingers in a sequential manner to smoothly dislodge the
cell pellet from the tube bottom.
9. Resuspend each iPSCs pellet in 0.5 mL of cold (4C) CRYO-
STEM/freezing medium and carefully pipette up and down
four to five times with a 5-mL pipette until cell clumps are uni-
formly suspended.
10. Transfer the cell suspension to 1.5-mL cryovials with a 5-mL
pipette.
Note: at this point, the cells are in contact with DMSO, and they should
therefore be quickly aliquoted and frozen (±5 min) since exposure of
the cells to DMSO at RT is toxic for the cells.28rapy: Methods & Clinical Development Vol. 23 December 2021 573
Table 1. Summary of the different matrices and culturemedia tested for the
adaptation of the iPSCs to feeder-free culture conditions
Matrix Culture medium Results
Matrigel
cHFFa
fragments of colonies adhered after the first
manual passage but not after the second one
Essential 8b
fragments of colonies adhered after the
first manual passage but differentiated
areas appeared
Tips and tricks for iPSCs culture Molecular Therapy: Methods & Clinical Development11. Introduce the cryovials containing the cell suspension in a
freezing container and store at 80C for 24 h.
12. Transfer the cryovials to a liquid nitrogen tank for long-term
storage.
Note: we recommend performing this process (option A or option B)
after every passage, until enough backup vials (approximately five
vials per line) have been frozen.mTeSR Plusb
good colony morphology; low cell death;
possible to expand without differentiation
Vitronectin
Essential 8b fragments of colonies did not adhere
mTeSR Plusb
fragments of colonies adhered to the
culture dishes, but debris and
differentiated cells were observed
Geltrex
Essential 8b fragments of colonies did not adhere
StemFlexb fragments of colonies did not adhere
DEF-CS DEF-CS
a number of clones lost the ESC-like
colony morphology
rh-Laminin-521 StemFlexb
after a number of passages, some clones
lost the ESC-like colony morphology
aTested with and without 1 mL/mL of ROCK inhibitor Y-27632.
bTested with and without 10 mL/mL of RevitaCell 100X. cHFF, conditioned medium
from non-dividing human foreskin fibroblasts; ESC, embryonic stem cell.Thawing iPSCs
1. Prepare 10 mL of pre-warmed (37C) hESC medium containing
1 mL/mL of 10 mM Rho-associated protein kinase (ROCK) in-
hibitor Y-27632 (final concentration 10 mM) in 15-mL conical
tubes.
2. Take the desired frozen vials of iPSCs from the liquid nitrogen
tank and keep on ice until reaching the water bath.
3. Quickly thaw the iPSCs (<1 min) by gently swirling the vial in the
37C water bath, until just a small bit of ice is left in the vial.
4. At this point, spray the cryovials with 70% ethanol and place inside
the laminar flow hood.
5. Open the cryovials and add 1 mL of pre-warmed hESC medium in
a dropwise manner.
6. Transfer the 1-mL cell suspension to the 15-mL conical tubes pre-
pared in step 1.
Note: pipette the iPSCs carefully, so that cell clumps are not broken
into single cells.
7. Centrifuge the tubes at 200  g for 4 min.
8. Aspirate the supernatant and gently resuspend pelleted cell clumps
in 1 mL of pre-warmed hESC medium.
Note: 1 mL of the iPSC suspension is transferred to one well of a six-
well plate seeded with feeder cells and already containing 1 mL of
hESC medium +1 mL/mL ROCK inhibitor (final concentration
10 mM).
9. Place the six-well culture dishes containing the thawed iPSCs in
the incubator (37C and 5% CO2) and leave undisturbed for 48 h.
10. From 48 h onward, replace the 2 mL of hESC medium every day.
Note: we recommend not aspirating all the medium but
leaving ±0.5 mL of medium before adding 2 mL of fresh hESC
medium
11. Check the culture plates daily under the microscope to identify
iPSC colonies.Adaptation to feeder-free conditions
Note: in this methodological article, we describe and test different cul-
ture media (either commercial or “lab-made”) combined with
different matrix coatings and subculture methods, to determine the
best method to adapt the generated iPSCs to feeder-free conditions
(Table 1).574 Molecular Therapy: Methods & Clinical Development Vol. 23 DecemLab-made culture media
Note: lab-made media is obtained from conditioned media, which is
prepared by collecting supernatants from a monolayer of mitotically
inactivated HFF (cHFF) as described below.
1. Follow the protocol described in “Preparation of a stock of feeder
cells” (see also “Expansion of the cells and irradiation”) to mitot-
ically inactivate HFF-1 cells.
2. Seed the irradiated HFF-1 cells in 100-mm culture dishes coated
withMatrigel solution to have a confluency of 95%–100%, and cul-
ture them in hESC medium without bFGF.
Note: to prepare Matrigel-coated dishes see “Culture of iPSCs onto
feeder cells” (see also “Seeding of feeder cells on six-well plates”).
For recommended volumes in a 100-mm dish refer to Table 2.
3. Every 24 h, refresh the medium of the 100-mm plates keeping the
conditioned medium in a sterile bottle and store it at 4C. Condi-
tioned medium without bFGF can be stored at 4C for up to
2 months.
4. Before its usage, pass the conditioned medium through a 0.22-mm
filter to remove cell debris and add 1 mg/mL of bFGF.
Commercial culture media
Besides lab-made culture media, four different commercial media
were tested in this study, following the manufacturer’s instructions:
Essential 8 (Thermo Fisher Scientific, Spain), StemFlex (Gibco,
Thermo Fisher Scientific), mTeSR Plus (STEMCELL Technologies),
and Cellartis defined culture system (DEF-CS) (Takara Bio).ber 2021








6-well plate 10 cm2/well 2 mL
12-well plate 4 cm2/well 0.8 mL
24-well plate 2 cm2/well 0.4 mL
35-mm dish 10 cm2 2 mL
60-mm dish 20 cm2 4 mL
100-mm
dish
60 cm2 12 mL
Vitronectin
6-well plate 10 cm2/well 1 mL/well
12-well plate 4 cm2/well 0.4 mL/well
24-well plate 2 cm2/well 0.2 mL/well
35-mm dish 10 cm2 1 mL
60-mm dish 20 cm2 2 mL
100-mm
dish
60 cm2 6 mL
Rh-
Laminin-521
6-well plate 10 cm2/well 2 mL
12-well plate 4 cm2/well 0.8 mL
24-well
plate
2 cm2/well 0.4 mL
35-mm dish 10 cm2 2 mL
60-mm dish 20 cm2 4 mL
100-mm
dish
60 cm2 12 mL
Geltrex
6-well plate 10 cm2/well 1.5 mL
12-well
plate
4 cm2/well 0.6 mL
24-well plate 2 cm2/well 0.3 mL
35-mm dish 10 cm2 1.5 mL
60-mm dish 20 cm2 3 mL
100-mm
dish
60 cm2 6 mL
COAT-1
6-well plate 10 cm2/well 1.5 mL
12-well
plate
4 cm2/well 0.6 mL
24-well plate 2 cm2/well 0.3 mL
35-mm dish 10 cm2 1.5 mL
60-mm dish 20 cm2 3 mL
100-mm
dish






6-well plate 10 cm2/well 1 mL
12-well
plate
4 cm2/well 0.4–1 mL
24-well
plate
2 cm2/well 0.2–0.3 mL
35-mm dish 10 cm2 1 mL
60-mm dish 20 cm2 3 mL
100-mm
dish










6-well plate 10 cm2/well 2 mL
12-well
plate
4 cm2/well 1–2 mL
24-well
plate
2 cm2/well 0.5–1 mL
35-mm dish 10 cm2 2 mL
60-mm dish 20 cm2 5 mL
100-mm
dish
60 cm2 12 mL
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Molecular TheMatrix coatings and culture media combinations
Vitronectin:
1. Thaw one vitronectin aliquot at RT.
2. Prepare vitronectin by diluting it in PBS without Ca2+ and Mg at
RT in a 1:100 ratio as recommended by the manufacturer (i.e.,
60 mL of vitronectin in 6 mL of PBS without Ca2+ and Mg). Gently
resuspend by pipetting up and down.
3. Add 1 mL of vitronectin solution to each well of a six-well plate,
ensuring that all the surface is completely covered.
Note: for recommended volumes in other culture surfaces refer to Ta-
ble 2.
4. Incubate for 1 h at RT.
5. After the 1-h incubation, aspirate the vitronectin solution and
discard. No rinsing is needed.
6. Immediately plate the iPSCs in 2 mL/well of pre-warmed cell cul-
ture medium.
Matrigel matrix:
1. Prepare the Matrigel solution as described in the “reagent setup”
section.
2. Prepare Matrigel-coated dished as described in “Culture of iPSCs
onto feeder cells”(see also “Seeding of feeder cells on six-well
plates”). For recommended values in other culture surfaces refer
to Table 2.
3. Add 2 mL/well of culture medium before seeding the iPSCs.
rh-Laminin-521:
Note: the optimal concentration of rh-laminin-521 should be deter-
mined empirically. Here, we use a working concentration of 2.5 mg/
mL as recommended by the manufacturer and the instructions are
given to coat a six-well plate. For recommended volumes in other cul-
ture surfaces refer to Table 2.
1. To coat a six-well plate, slowly thaw one aliquot (300 mL) of the
20C rh-laminin-521 stock (see “reagent setup”) between 2C
and 8C.rapy: Methods & Clinical Development Vol. 23 December 2021 575
Tips and tricks for iPSCs culture Molecular Therapy: Methods & Clinical Development2. Once thawed, add the 300 mL of rh-laminin-521 to a 15-mL conical
tube containing 12 mL of PBS with Ca2+ and Mg and gently resus-
pend by pipetting up and down.
3. Add 2 mL of the rh-laminin-521 solution to each well of a six-well
plate, ensuring all the surface is completely covered.
4. Incubate at 37C for at least 2 h.
5. Carefully aspirate the rh-laminin-521 solution with a micropipette
and discard. No rinsing is needed.
6. Immediately plate the iPSCs in 2 mL/well of pre-warmed cell cul-
ture medium.
Geltrex:
1. Prepare Geltrex solution (1:100) in KO-DMEM with P/S (i.e.,
60 mL of Geltrex in 6 mL of KO-DMEM with P/S). Gently resus-
pend by pipetting up and down.
Note: empirical determinationofGeltrex concentrationmaybe required.
2. Add 1 mL of Geltrex solution to each well of a six-well plate,
ensuring that all the surface is completely covered.
Note: for recommended volumes in other culture surfaces refer to Ta-
ble 2.
3. Incubate 1 h at 37C followed by 1 h at RT.
4. Aspirate the Geltrex coating and immediately plate the iPSCs in
2mL/well of pre-warmed cell culturemedium.No rinsing is needed.
COAT-1:
Note: COAT-1 is the coating from the DEF-CS kit.
1. PrepareCOAT-1 bydiluting it in a 1:20proportion inPBSwithCa2+
and Mg and mix gently and thoroughly by pipetting up and down.
2. Add 1.5 mL of COAT-1 solution to each well of a six-well plate,
ensuring that all the surface is completely covered. For recommen-
ded volumes in other culture dishes refer to Table 2.
3. Incubate the dishes at 37C overnight.
4. The following day, carefully remove the remaining solution and
immediately plate the iPSCs in 2 mL/well of pre-warmed DEF-
CS cell culture medium. No rinsing is needed.
Note: before adding DEF-CS culture medium, incorporate growth
factors 1, 2, and/or 3 following the manufacturer’s instructions.
Cell passaging for feeder-free adaptation of iPSCs
1. Prepare the culture dishes in advance as described in the previous
section (“Matrix coatings and culture media combinations”).
2. Identify the iPSC colonies that are ready to pick and proceed as
described in “Culture of iPSCs onto feeder cells” (see also “Picking
iPSC colonies”) until step number 7.
3. Carefully transfer the iPSC fragments from 10 to 12 colonies to each
well of a 6-well plate containing2mL/well of culturemediumsupple-
mented with 1mL/mL (10 mM) of 10 mM ROCK inhibitor Y-27632.576 Molecular Therapy: Methods & Clinical Development Vol. 23 DecemNote: as a start point, picking and seeding the double of colonies per
well is recommended since cell death is normally high after the first
passage to feeder-free culture conditions.
Note: when using the DEF-CS kit, no ROCK inhibitor was added to
the culture medium.
4. Once a six-well plate is completed, bring it back to the incubator
and delicately move it in a cross-shaped manner to homogeneous-
ly distribute the fragments.
5. Let the colonies grow with daily medium changes.
Note: it is possible to change the medium immediately after the first
24 h post seeding.
Cell passaging for feeder-free sub-culturing of iPSCs
1. Perform sub-culturing of the iPSCs once the colonies are grown
and with a confluency of approximately 80%.
2. For the first two passages after feeder-free adaptation of the iPSCs,
manually split the colonies using the stripper micropipette as
described in “Culture of iPSCs onto feeder cells” (see also “Picking
iPSC colonies”).
3. From the second passage onward, different reagents can be used to
detach the cells, either in clamps (option A) or single cells (option
B), depending on the experimental needs.
4. To obtain clamps of cells (option A) incubate the iPSC-containing
plates with non-enzymatic Versene solution for 3–5 min or with
gentle cell dissociation reagent for 8 min at 37C. For recommen-
ded volumes refer to Table 2.
5. Carefully remove Versene or gentle cell dissociation reagent after
the incubation time.
Note: remove Versene or gentle cell dissociation reagent carefully so
the cells are not detached from the culture dish.
6. Gently detach the iPSC colonies by flushing fresh warm culture
medium.
Note: when flushing fresh culture medium, we recommend doing it
with a 5- to 10-mL pipette, so that the cell clumps are not broken
into single cells.
7. Aspirate the cell clump suspension with a 5- to 10-mL pipette and
transfer it to a 15-mL conical tube and gently pipette it up and
down 5–7 times before transferring to a new plate to ensure that
the size of the fragments is appropriate.
Note: colony fragments obtained with gentle cell dissociation reagent
should be transferred directly to the new plate.
8. Let the cell clumps spontaneously sediment by gravity at the bot-
tom of the tube (%5 min) and remove supernatant without dis-
turbing the pelleted clumps.
9. Resuspend the iPSC fragments in the appropriate amount of warm
medium (i.e., 2 mL/well of a six-well plate) and seed in a biggerber 2021
Figure 2. Generation of feeder cells
(A) Scheme representing the followed workflow to generate the stock of feeder cells. Scheme prepared with BioRender. (B) Histogram representing the results of the cell-
cycle analysis by flow cytometry. Irradiation of the foreskin fibroblast cell line HFF-1 at 75 Gy (green line) caused cell-cycle arrest (arrow), in comparison with unirradiated HFF-
1 cells (purple area). (C) Homogeneous monolayer of feeder cells at >80% confluency. Scale bar, 200 mm.
www.moleculartherapy.org Tips and tricks for iPSCs culturesurface for cell expansion. For recommended volumes in other cul-
ture surfaces refer to Table 2.
Note: we recommend starting with a split ratio of 1:2 or 1:3, meaning
the iPSC colonies are contained in one well to two or three new wells
of a six-well plate, and subsequently increase this ratio as the feeder-
free cultures of iPSCs are more established.
10. To obtain a single-cell suspension (option B), incubate the iPSCs
with TrypLE Select Enzyme 1X diluted 1:10 in PBS, for 5 min at
37C.
11. After the 5-min incubation, inactivate TrypLE Select Enzyme 1X
by gently adding one volume of fresh warm culture medium.
12. Carefully collect the cell suspension in a 15-mL conical tube.
Note: cells can be counted using trypan blue and a Neubauer chamber.
13. Centrifuge the tube at 280 g for 5 min to obtain a cell pellet and
resuspend in the desired volume of medium for performing
downstream analysis.
Note: better survival of single iPSCs has been observed when seeded
in rh-laminin-521-coated dishes.
OUTCOMES
Generation of feeder cells and subsequent iPSC culture
Cell-cycle analysis showed that the irradiation of the foreskin fibro-
blast cell line HFF-1 at 75 Gy caused cell-cycle arrest of irradiatedMolecular TheHFF-1 cells, in comparison with unirradiated HFF-1 cells (Figure 2B).
Therefore, this radiation dose together with the protocol described
above were established as effective to generate the stocks of feeder
cells. The number of feeder cells that were seeded in the culture dishes
for culturing and expanding the iPSC colonies was adjusted to achieve
a homogeneous monolayer of feeder cells at >80% confluency (Fig-
ure 2C). To achieve this, a total of 2  106 feeder cells were seeded
in five wells of a six-well plate (cell density of ±4  104 cells/cm2).
Regarding the iPSC culture onto feeder cells, it was observed that, using
the protocol described in the ’culture of iPSCs onto feeder cells’ section,
fragments of iPSC colonies after picking were able to formnew colonies
onto feeder cells. These new colonies displayed the desired typical iPSC
morphology (Figure 1B): compact colonies withwell-defined edges and
comprised of cells with high nucleus/cytoplasm ratio29,30 and were
ready to pick every 5–9 days, depending on the clone.
Troubleshooting
Problem:
 iPSC colonies are not growing after passaging or they spontane-
ously differentiate.
Possible reasons/solution:
 Differentiated colonies or areas of colonies are common at early
passages. Avoiding picking the differentiated colonies/areas andrapy: Methods & Clinical Development Vol. 23 December 2021 577
Figure 3. Comparison of iPSC freezing media
Images from stereomicroscope of (A) colonies growing onto
feeder cells, which appeared 15 days after thawing when
using freezing medium consisting of 90% FBS and 10%
DMSO. (B) Colonies growing onto feeder cells, which ap-
peared 4 to 5 days after thawing.
Tips and tricks for iPSCs culture Molecular Therapy: Methods & Clinical Developmenttransferring only undifferentiated colonies to a new plate will in-
crease the quality of the cultures. It is very likely that the number
of colonies to be picked needs to be increased right after the reprog-
ramming.
 The quality of feeders is absolutely crucial to maintain the iPSCs.
Therefore, we recommend not to use feeder cells that have been
stored in liquid nitrogen for more than 3 months.
 Inappropriate size of pieces of colonies when picking decreases the
viability of iPSCs. It is important that the fragments of iPSC col-
onies have the appropriate size (small clumps of 175 mm), as
big clumps (>250 mm) cannot adhere, and small ones (<100 mm)
do not survive well.
 We found that the recovery rate after passaging was improved
when keeping the plates undisturbed in the incubator for 48 h
before refreshing the culture medium. In addition, when hESCme-
dium of each well is changed, not all the medium is aspirated but
0.5 mL of medium is left before adding 2 mL of fresh hESC me-
dium.
Maintenance and stocking of iPSC cultures
Both the freezing protocol employing CRYOSTEM hPSC freezing
medium and the one employing freezing medium consisting of 90%
FBS and 10% DMSO showed good recovery rates after thawing. To
note, when iPSCs were frozen using the freezing medium (90% FBS
and 10% DMSO) the recovery rate was slightly lower, and if colonies
finally appeared in culture, they appeared as late as 15 days after thaw-
ing (Figure 3A). On the contrary, when using the CRYOSTEM,
compact colonies begun to grow 4–5 days after thawing (Figure 3B).
Considering this, the freezing protocol was established using the
CRYOSTEM and following the instructions described in the method-
ology section, but both protocols are suitable for cryopreserving
iPSCs, as previously reported.31
Troubleshooting
Problem:
 From very low to non-recovery of the iPSCs after thawing.
Possible reasons/solution:
 Make sure that only healthy colonies are cryopreserved and avoid
picking differentiated areas. Differentiated areas should not exceed
20% of the well if the culture is of high quality.32578 Molecular Therapy: Methods & Clinical Development Vol. 23 Decem To increase the number of cryopreserved colonies per vial may be
needed. In our experience, cryopreserving <10 iPSC colonies leads
to almost non-recovery of the cells after thawing. Ideally, one com-
plete well of healthy colonies is recommended to ensure recovery
after thawing. Leftovers from wells already picked cannot be
considered healthy colonies even when the morphology resembles
them. If still unsuccessful, we recommend testing different den-
sities of freezing/thawing (e.g., one well of a six-well plate, two wells
of a six-well plate, or three wells of a six-well plate).
 Ensure that the fragments of the iPSC colonies have the appro-
priate size (small clumps of 175 mm) since dissociation to single
cells decreases the viability.
 Perform both freezing and thawing processes quickly but
gently.
 We have found it to be crucial to use freezing containers that enable
a slow rate-controlled cooling protocol, such as the CoolCell.iPSC culture on feeder-free conditions
Tested protocols
A number of combinations were tested as summarized in Table 1.
Matrigel-coated plates together with cHFF medium were used for
the first adaptation attempt. After the first passage, performed me-
chanically with a stripper micropipette, the iPSC fragments adhered
to the plate, appearing under the microscope as small clusters of
compact cells that grewmaintaining the rounded colonymorphology.
Nonetheless, when performing the next passaging—both mechani-
cally, using 0.05% trypsin-EDTA or Versene—the colony fragments
did not adhere to the plate and remained as floating fragments. Addi-
tion of 1 mL/mL (10 mM) of ROCK inhibitor Y-27632 to the culture
medium improved survival and adherence of the iPSC colonies frag-
ments when passaged as previously reported,33 except when using
trypsin-EDTA. However, from the fourth passage onward, the colony
fragments remained suspended in the culture medium and did not
adhere to the plates. Therefore, it was not possible to either grow or
expand iPSCs with this system.
The commercial culture medium Essential 8 was next used in combi-
nation with Matrigel-coated dishes. On the first passage, culture
mediumwas supplemented with 10 mL/mL of RevitaCell 100X, as rec-
ommended by the manufacturer (Figure 4A). In this case, adhered
iPSC colony fragments were observed. When iPSCs proliferated in
culture and colonies increased in size, differentiated areas appeared,ber 2021
Figure 4. Adaptation to feeder-free culture conditions
Representative images of the results obtained when testing
different combinations of matrices and culture media to
adapt iPSCs to feeder-free culture conditions. (A) Matrigel in
combination with Essential 8 medium. (B) Vitronectin in
combination with mTeSR Plus medium. (C) DEF-CS system.
(D) rh-Laminin-521 in combination with StemFlex medium.
(E) Matrigel in combination with mTeSR Plus. Second and
third image of row (A) were taken with SMZ-745T stereo-
microscope coupled to a real-time DS-FI2 photomicrograph
camera. The rest of the images were taken employing an
Olympus BX51 Mmicroscope coupled to an Olympus DP70
digital camera. Scale bars, 100 mm.
www.moleculartherapy.org Tips and tricks for iPSCs cultureespecially in the central part of the colonies, which occasionally
formed spontaneous embryoid bodies (EBs).
Two more adaptation tests were performed using Essential 8 medium,
both supplemented andnon-supplementedwith 10mL/mLof RevitaCell
100X, in combination with two different matrices: vitronectin and Gel-
trex. In these two systems, colony fragments did not adhere to the plates
after the first manual passage. The same results were observed when the
Geltrexmatrix was combinedwith the StemFlex culturemedium.When
vitronectin was used in combination with mTeSR Plus (Figure 4B), the
cells adhered to the culturedishes, but debris anddifferentiated cellswere
observed. Grown colonies were not compact and disappeared with time.
In the DEF-CS culture system, iPSCs cells grew as rounded colonies
after the first manual passage (Figure 4C) and it was possible to
perform subcultures both mechanically and enzymatically. However,
colonies of some clones lost the ESC-like morphology characterized30
by the high nucleus-to-cytoplasm ratio, defined borders, and promi-
nent nucleoli, rather tending to spread out.Molecular Therapy: Methods & ClWhen the iPSC clones were adapted to the culture
system consisting of a rh-laminin-521 matrix and
the StemFlex culture medium (Figure 4D), high
cell death and abundant colony fragments sus-
pended in the culture medium were observed after
the first manual passage. Once the medium was
refreshed, the small groups of cells that had
attached to the plates began to proliferate as col-
onies with defined borders and compact
morphology. From 5 to 6 days after the first pas-
sage, a second manual subculture was performed.
The third subculture was carried out 5–6 days
later, using the Versene enzyme, and iPSCs prolif-
erated with the typical undifferentiated ESC-like
colony morphology. In addition to these recom-
mendations, the two first passages in feeder-free
conditions were performed manually with the
stripper micropipette. Once the cells had been
enzymatically subcultured for 3 to 4 times, cells
were seeded in 1:20 proportion to ensure that
iPSC colonies grew undifferentiated until 90%confluency was reached. StemFlex culture mediumwas supplemented
with 10 mL/mL of RevitaCell 100X only when cells were passaged.
Given the good results obtained, we initially consider this protocol
to be implemented for culturing and expanding the iPSCs in
feeder-free conditions. However, colonies of some clones showed a
peculiar “half-moon” shape morphology (Figure 4D, third image)
and formed sporadically spontaneous EBs.
Finally, we tested a similar protocol but with a different combination
of culture media (mTeSR Plus) and matrix (Matrigel): (1) the two first
passages in feeder-free conditions were performed manually with the
stripper micropipette; (2) from the second passage onward, iPSCs
were subcultured by using gentle cell dissociation reagent; (3) culture
medium was supplemented with 10 mL/mL of RevitaCell 100X only
when cells were passaged. Using this method, colonies with defined
borders and compact morphology were obtained, and low cell debris
and differentiation are observed (Figure 4E). Therefore, it was the
finally established method for culturing and expanding the iPSCs in
feeder-free conditions.inical Development Vol. 23 December 2021 579
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Problem:
 iPSC fragments do not attach to the plates after passaging.
 The main part of the iPSC colonies growing on feeder-free condi-
tions start to differentiate.
Possible reasons/solution:
 Appropriate size of the iPSC colony fragments is essential. If the
clumps are too big (>200 mm), the cells will not be attached to
the plate and they will tend to form spontaneous EBs. On the con-
trary, too small fragments (<100 mm) or single cells34 are more
prone to differentiation.
 We have observed that performing the first two to three passages in
a manual way improves cell survival and adaptation efficiency. In
addition, supplementation of the culture medium with RevitaCell
100X or ROCK inhibitor Y-27632 may also improve survival and
adherence of the iPSC colonies fragments when passaged.33 To
note, a certain number of differentiated cells in the culture is
normal, especially during the first passages. These cells should
disappear with medium changes.
 Revise the concentration of the coatings employed since empirical
determination may be required as suggested by the manufacturer’s
instructions.
 Difficult-to-adapt iPSC lines may be affected by the change of the
culture mediumwhen transferred to a feeder-free system. Perform-
ing a gradual transition combining the culture medium used in the
feeder-based system with the culture medium of the feeder-free
system (1:1 proportion) could help to diminish this risk.
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